AI
PRAH

Axiom Investors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Axiom Investors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,832
Closed -$693K – 140
2020
Q3 		$693K Sell
6,832
-165
-2% -$16.8K 0.01% 107
2020
Q2 		$681K Sell
6,997
-7,732
-52% -$720K 0.01% 111
2020
Q1 		$1.22M Sell
14,729
-27,590
-65% -$2.69M 0.03% 98
2019
Q4 		$4.7M Sell
42,319
-4,999
-11% -$514K 0.11% 81
2019
Q3 		$4.7M Sell
47,318
-314
-0.7% -$31.2K 0.13% 73
2019
Q2 		$4.72M Buy
47,632
+524
+1% +$50K 0.13% 70
2019
Q1 		$5.2M Sell
47,108
-22,679
-32% -$2.37M 0.16% 66
2018
Q4 		$6.42M Sell
69,787
-7,058
-9% -$714K 0.22% 62
2018
Q3 		$8.47M Buy
76,845
+7,614
+11% +$793K 0.24% 61
2018
Q2 		$6.46M Sell
69,231
-61,886
-47% -$5.33M 0.19% 68
2018
Q1 		$10.9M Sell
131,117
-12,692
-9% -$1.13M 0.27% 62
2017
Q4 		$13.1M Buy
143,809
+19,985
+16% +$1.66M 0.33% 59
2017
Q3 		$9.43M Sell
123,824
-2,578
-2% -$195K 0.21% 72
2017
Q2 		$9.48M Buy
126,402
+12,724
+11% +$882K 0.23% 64
2017
Q1 		$7.42M Sell
113,678
-3,004
-3% -$177K 0.19% 66
2016
Q4 		$6.43M Buy
116,682
+86,606
+288% +$4.75M 0.18% 69
2016
Q3 		$1.7M Buy
+30,076
New +$1.47M 0.05% 87

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Axiom Investors's PRAH Position: Q4 2020 in Review

Axiom Investors sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 6,832 shares — an estimated $693K sold.

Axiom Investors first reported a position in PRAH in Q3 2016 and held it in 17 quarters. The position peaked at $13.1M in Q4 2017. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

  • Axiom Investors reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Axiom Investors sold 6,832 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $693K.
  • Axiom Investors first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 17 quarters.
  • Axiom Investors's PRA Health Sciences, Inc. position peaked at $13.1M in Q4 2017.
  • 289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Axiom Investors's 13F filing for Q4 2020, filed 12 Feb 2021.